|
PPP1CC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
8.16380000000505E-05 |
| Normal-vs-Stage3 |
4.07459999962612E-07 |
| Normal-vs-Stage4 |
4.52829995722936E-09 |
| Stage1-vs-Stage2 |
6.308600E-01 |
| Stage1-vs-Stage3 |
2.018400E-01 |
| Stage1-vs-Stage4 |
9.938000E-01 |
| Stage2-vs-Stage3 |
6.994200E-01 |
| Stage2-vs-Stage4 |
6.723000E-01 |
| Stage3-vs-Stage4 |
3.372600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.034000E-02 |
| Normal-vs-Asian |
1.454980E-01 |
| Caucasian-vs-AfricanAmerican |
1.54640000027406E-07 |
| Caucasian-vs-Asian |
4.487600E-01 |
| AfricanAmerican-vs-Asian |
2.986400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
4.63240557024847E-12 |
| Male-vs-Female |
1.048030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.816330E-03 |
| Normal-vs-Age(41-60Yrs) |
4.21884749357559E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62547753035369E-12 |
| Normal-vs-Age(81-100Yrs) |
3.079500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.439200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.103200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.634190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.253000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.626200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.341800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.12609999999946E-05 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
1.71407332771878E-12 |
| Normal-vs-Grade 4 |
6.1792000000005E-05 |
| Grade 1-vs-Grade 2 |
3.871400E-01 |
| Grade 1-vs-Grade 3 |
7.897400E-01 |
| Grade 1-vs-Grade 4 |
6.130600E-01 |
| Grade 2-vs-Grade 3 |
1.549950E-02 |
| Grade 2-vs-Grade 4 |
3.464200E-02 |
| Grade 3-vs-Grade 4 |
4.978600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.84659953994526E-10 |
| ccA subtype-vs-ccB subtype |
2.838200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62625468647093E-12 |
| Normal-vs-N1 |
1.696400E-02 |
| N0-vs-N1 |
7.438000E-01 |
|
|
